Predictive Oncology Inc. (POAI)
NASDAQ: POAI · Real-Time Price · USD
4.260
-1.220 (-22.26%)
At close: Dec 5, 2025, 4:00 PM EST
4.840
+0.580 (13.62%)
After-hours: Dec 5, 2025, 7:54 PM EST
Predictive Oncology Market Cap
Predictive Oncology has a market cap or net worth of $14.46 million as of December 5, 2025. Its market cap has increased by 221.25% in one year.
Market Cap
14.46M
Enterprise Value
16.17M
1-Year Change
221.25%
Ranking
Category
Stock Price
$4.26
Market Cap Chart
Since August 31, 2015, Predictive Oncology's market cap has increased from $13.20M to $14.46M, an increase of 9.52%. That is a compound annual growth rate of 0.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 18.60M | 238.18% |
| Dec 31, 2024 | 5.50M | -58.96% |
| Dec 29, 2023 | 13.40M | -44.40% |
| Dec 30, 2022 | 24.10M | -61.38% |
| Dec 31, 2021 | 62.40M | 383.72% |
| Dec 31, 2020 | 12.90M | 27.72% |
| Dec 31, 2019 | 10.10M | 16.09% |
| Dec 31, 2018 | 8.70M | 38.10% |
| Dec 29, 2017 | 6.30M | -33.68% |
| Dec 30, 2016 | 9.50M | -37.50% |
| Dec 31, 2015 | 15.20M | 15.15% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 936.68B |
| Johnson & Johnson | 494.92B |
| AbbVie | 396.55B |
| UnitedHealth Group | 293.98B |
| AstraZeneca | 282.37B |
| Novartis AG | 253.36B |
| Merck & Co. | 250.76B |
| Abbott Laboratories | 219.65B |